Journal News

Probing for a ketone body’s link to age-related inflammation

Meric Ozturk
Aug. 24, 2023

Glucose levels in the blood and cells are regulated by the pancreatic hormones insulin and glucagon. While insulin helps cells to take in glucose and reduces blood glucose levels, glucagon initiates the conversion of stored glycogen to glucose.

When glucose is depleted, insulin levels decrease but glucagon levels remain stable. In cells, this triggers the release of fats, which are converted into different types of ketone bodies by the enzyme 3-Hydroxy-3-methylglutaryl-CoA, or HMGCL, in the liver. One of these ketone bodies, beta-hydroxybutyrate, or BHB, can be an energy source for the brain and skeletal muscle when blood glucose is low. Several studies have also shown that BHB also plays a role in the signaling pathways of lipolysis and aging.

Neutrophils are the most abundant type of white blood cells in the human body and play an important role in inflammation.
Neutrophils are the most abundant type of white blood cells in the human body and play an important role in inflammation.

Emily Goldberg, a researcher at the University of California, San Francisco, studies NOD-, LRR- and pyrin domain-containing protein 3, known as NLRP3, and how this protein interacts with BHB. NLRP3 helps to regulate the innate immune system and inflammatory signaling as well as age-related inflammation.

“We had previously shown that the NLRP3 drives age-related inflammation and that the ketone body BHB inhibits NLRP3 activation in macrophages and neutrophils, so we hypothesized that BHB might inhibit age-related inflammation,” Goldberg said.

Although most ketone bodies are produced in liver cells, researchers hypothesize that they also can be synthesized by cells from other tissues, including macrophages and neutrophils.

To test their hypothesis about BHB, Goldberg and a team of researchers from UCSF and the Yale School of Medicine used mice from which they deleted the gene that encodes the HMGCL enzyme. This helped them prevent ketone body synthesis in specific cell types, namely macrophages and neutrophils.

“Making the mice to test this hypothesis and planning the experiments to have enough aged mice was the most difficult part of the study,” Goldberg said.

The team compared the role of liver-based ketone body formation with that of cell-specific ketone body formation in age-related inflammation.

In their recent paper published in the Journal of Biological Chemistry, the researchers point out that the liver is the only organ that can produce enough ketone bodies to maintain blood glucose levels, and neutrophil-based ketogenesis does not regulate age-related metabolic health.

“Exogenous ketones are likely responsible for controlling innate immune inflammation in aging,” Goldberg said, “Macrophages can metabolize acetoacetate, but not BHB and this is important for their function. But why innate immune cells take up BHB remains unclear.”

The group only used a single mouse strain; using other strains and different mutations in different enzymes in the ketone body formation pathway could show different results. Goldberg said that next they will consider all these limitations and aim to determine why innate immune cells take up BHB.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Meric Ozturk

Meric Ozturk is a Ph.D. student in biochemistry at Iowa State University and an ASBMB Today volunteer contributor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Training AI to uncover novel antimicrobials
Feature

Training AI to uncover novel antimicrobials

Oct. 9, 2025

Antibiotic resistance kills millions, but César de la Fuente’s lab is fighting back. By pairing AI with human insight, researchers are uncovering hidden antimicrobial peptides across the tree of life with a 93% success rate against deadly pathogens.

AI-designed biomarker improves malaria diagnostics
Journal News

AI-designed biomarker improves malaria diagnostics

Oct. 8, 2025

Researchers from the University of Melbourne engineered Plasmodium vivax diagnostic protein with enhanced yield and stability while preserving antibody-binding, paving the way for more reliable malaria testing.

Matrix metalloproteinase inhibitor reduces cancer invasion
Journal News

Matrix metalloproteinase inhibitor reduces cancer invasion

Oct. 8, 2025

Scientists at the Mayo Clinic engineered a TIMP-1 protein variant that selectively inhibits MMP-9 and reduces invasion of triple-negative breast cancer cells, offering a promising tool for targeted cancer research.

Antibiotic sensor directly binds drug in resistant bacteria
Journal News

Antibiotic sensor directly binds drug in resistant bacteria

Oct. 8, 2025

Researchers at Drexel University uncover how the vancomycin-resistant bacterial sensor binds to the antibiotic, offering insights to guide inhibitor design that restores antibiotic effectiveness against hospital-acquired infections.

ApoA1 reduce atherosclerotic plaques via cell death pathway
Journal News

ApoA1 reduce atherosclerotic plaques via cell death pathway

Oct. 1, 2025

Researchers show that ApoA1, a key HDL protein, helps reduce plaque and necrotic core formation in atherosclerosis by modulating Bim-driven macrophage death. The findings reveal new insights into how ApoA1 protects against heart disease.

Omega-3 lowers inflammation, blood pressure in obese adults
Journal News

Omega-3 lowers inflammation, blood pressure in obese adults

Oct. 1, 2025

A randomized study shows omega-3 supplements reduce proinflammatory chemokines and lower blood pressure in obese adults, furthering the understanding of how to modulate cardiovascular disease risk.